Dongwha Pharm Co Ltd
KRX:000020
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dongwha Pharm Co Ltd
KRX:000020
|
KR |
|
T
|
Tai United Holdings Ltd
HKEX:718
|
HK |
|
Panin Financial Tbk PT
IDX:PNLF
|
ID |
|
A
|
Asian Terminals Inc
XPHS:ATI
|
PH |
|
K
|
KGHM Polska Miedz SA
OTC:KGHPF
|
PL |
|
Deutsche Industrie REIT-AG
XETRA:JB7
|
DE |
|
A
|
Anglo-Eastern Plantations PLC
LSE:AEP
|
UK |
|
Sofina SA
XBRU:SOF
|
BE |
|
E-Mart Inc
KRX:139480
|
KR |
|
C
|
Cognetivity Neurosciences Ltd
CNSX:CGN
|
CA |
|
E
|
EnSync Inc
OTC:ESNC
|
US |
|
P
|
Purefun Group AB (publ)
STO:PURE
|
SE |
|
Cresco Ltd
TSE:4674
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Dongwha Pharm Co Ltd's stock price target?
Not Available
Dongwha Pharm Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Dongwha Pharm Co Ltd's Revenue forecast?
Projected CAGR
-5%
For the last 13 years the
compound annual growth rate for
Dongwha Pharm Co Ltd's revenue is
5%.
The projected
CAGR
for the next 1 year is
-5%.
What is Dongwha Pharm Co Ltd's Operating Income forecast?
Projected CAGR
238%
For the last 13 years the
compound annual growth rate for
Dongwha Pharm Co Ltd's operating income is
-3%.
The projected
CAGR
for the next 1 year is
238%.
What is Dongwha Pharm Co Ltd's Net Income forecast?
Projected CAGR
605%
For the last 13 years the
compound annual growth rate for
Dongwha Pharm Co Ltd's net income is
-9%.
The projected
CAGR
for the next 1 year is
605%.
